Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
278
278 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- DB-3QPhase 22 trials
Direct Biologics, LLC · Perianal Fistula Due to Crohn's Disease, Crohn Disease (CD)
- DISC-0974Phase 22 trials
Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia
- EltrekibartLY3041658Phase 22 trials
Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa
- FB825Phase 22 trials
Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis
- GR2301Phase 22 trials
Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Vitiligo
- HB0043Phase 22 trials
Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa
- HSK39297 300mgQDPhase 22 trials
Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)
- HSK47388Phase 22 trials
Haisco Pharmaceutical Group Co., Ltd. · Plaque Psoriasis, Ulcerative Colitis (UC)
- ICG318Phase 22 trials
iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
- JAB-8263Phase 22 trials
Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC
- JYP0061Experimental Drug GroupPhase 22 trials
Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders
- LY4005130Phase 22 trials
Eli Lilly · Alopecia Areata, Vitiligo, Non-Segmental Vitiligo (NSV)
- LY4395089Phase 22 trials
Eli Lilly · Crohn Disease, Colitis, Ulcerative
- ModzatinibATI-2138Phase 22 trials
Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis
- NKX019Phase 22 trials
Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis
- ORKA-001Phase 22 trials
Oruka Therapeutics, Inc. · Plaque Psoriasis
- RosnilimabANB030Phase 22 trials
AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis
- SHR0302BasePhase 22 trials
Jiangsu HengRui Medicine Co., Ltd. · Vitiligo, Non-segmental Vitiligo
- SL-325Phase 22 trials
Shattuck Labs, Inc. · Crohn's Disease, Hidradenitis Suppurativa (HS)
- SPY001SPY001-001Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- SPY002SPY002-091Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- SPY002-072SPY072Phase 22 trials
Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis
- SPY003SPY003-207Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- TibulizumabZB-106Phase 22 trials
Zura Bio Inc · Hidradenitis Suppurativa (HS), Systemic Sclerosis (SSc), Scleroderma
- TollB-001Phase 22 trials
Toll Biotech Co. Ltd. (Beijing) · Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)
- TQB3702Phase 22 trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · B-cell Lymphoma, Systemic Lupus Erythematosus
- TrosunilimabABBV-382Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis
- vilamakitugXB2001, NatrunixPhase 22 trials
XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA
- VIS954Phase 22 trials
Otsuka · Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Inflammatory Skin Diseases
- XKH001InjectionXKH001Phase 22 trials
Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis
- YK012Phase 22 trials
Excyte Biopharma Ltd · Systemic Lupus Erythematosus (SLE), B-cell Acute Lymphoblastic Leukemia
- ABBV-547Phase 21 trial
AbbVie · Psoriatic Arthritis
- ABBV-668Phase 21 trial
AbbVie · Ulcerative Colitis
- ABBV-8736Phase 21 trial
AbbVie · Crohn's Disease
- ACT-777991Phase 21 trial
Idorsia Pharmaceuticals Ltd. · Non-Segmental Vitiligo
- AD-3031Phase 21 trial
Moogene Medi Co., Ltd · Androgenetic Alopecia
- AD-303APhase 21 trial
Moogene Medi Co., Ltd · Androgenetic Alopecia
- ADX-097Phase 21 trial
Akebia Therapeutics · IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy
- ALD-102Phase 21 trial
Aldena Therapeutics · Alopecia Areata (AA)
- ALTB-268Phase 21 trial
AltruBio Inc. · Ulcerative Colitis
- ATH-063Phase 21 trial
Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases
- ATI-045Phase 21 trial
Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis
- AZD1163Phase 21 trial
AstraZeneca · Rheumatoid Arthritis
- BBT001Phase 21 trial
Bambusa Therapeutics · Chronic Spontaneous Urticaria
- BGP-014Phase 21 trial
BioGaia Pharma AB · Ulcerative Colitis
- BI 3000202Phase 21 trial
Boehringer Ingelheim · Systemic Lupus Erythematosus
- BI 3032950Phase 21 trial
Boehringer Ingelheim · Ulcerative Colitis
- BMS-986528Phase 21 trial
Bristol Myers Squibb · Arthritis, Rheumatoid
- BriquilimabJSP191Phase 21 trial
Jasper Therapeutics, Inc. · Chronic Spontaneous Urticaria
- COL-5671-PROPhase 21 trial
Coultreon Biopharma · Plaque Psoriasis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.